Delpharm

EKAPARTNERS ADVISED DELPHARM ON TRANSFORMING ACQUISITIONS AND CUSTOMISED FINANCING

For years, we have been advising Delpharm, the fastest growing pharma Contract Development Manufacturing Organization (CDMO) in the successful acquisition of five manufacturing sites in France and abroad belonging to Famar, one of the largest player in the CDMO industry. We also advised the Group in the raising of a customized, highly competitive and flexible debt financing.
With these cross-border transactions, Delpharm now enjoys more than €800m turnover while keeping financial flexibility.